Nutritional countermeasures targeting reactive oxygen species in cancer: From mechanisms to biomarkers and clinical evidence

Antioxidants and Redox Signaling

Volumn 19, Issue 17, 2013, Pages 2157-2196

  Samoylenko, Anatoly ^a,b   Hossain, Jubayer Al ^a   Mennerich, Daniela ^a   Kellokumpu, Sakari ^a   Hiltunen, Jukka Kalervo ^a   Kietzmann, Thomas ^a  

^a UNIVERSITY OF OULU   (Finland)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; AMINO ACID; ASCORBIC ACID; BIOLOGICAL MARKER; CARBOHYDRATE; CAROTENOID; CATALASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FERRIC ION; GLUTATHIONE PEROXIDASE; HYDROETHIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; NITRONE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; PROTEIN C JUN; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROLOX C; UNINDEXED DRUG; YELLOW FLUORESCENT PROTEIN;

ANTIOXIDANT ACTIVITY; BLADDER CANCER; BREAST CANCER; CARCINOGENESIS; CAT; CELL CYCLE PROGRESSION; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; COLORECTAL CANCER; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG MEGADOSE; ELECTRON SPIN RESONANCE; ENERGY; ENZYME MECHANISM; EUKARYOTIC CELL; EVOLUTION; GENE TARGETING; GENETIC PREDISPOSITION; HUMAN; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LIVER CANCER; LUNG CANCER; MACRONUTRIENT; MASS FRAGMENTOGRAPHY; META ANALYSIS (TOPIC); MOLECULARLY TARGETED THERAPY; NONHUMAN; NUTRITION; OXIDATION; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SPIN TRAPPING; STOMACH CANCER; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARCINOGENESIS; DIET; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TUMOR MARKERS, BIOLOGICAL; VITAMINS;

EID: 84876461744     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4662     Document Type: Review

References (400)

1. Adams CH, Werely CJ, Victor TC, Hoal EG, Rossouw G, and van Helden PD. Allele frequencies for glutathione Stransferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence. Clin Chem Lab Med 41: 600-605, 2003.
2. Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, Berenguer T, Chirlaque MD, Dorronsoro M, Jakszyn P, Larranaga N, Martinez C, Navarro C, Quiros JR, Sanchez MJ, Tormo MJ, and Gonzalez CA. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin Nutr 85: 1634-1642, 2007.
3. Aguirre J and Lambeth JD. Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radic Biol Med 49: 1342-1353, 2010.
4. Ahmad KA, Clement MV, Hanif IM, and Pervaiz S. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res 64: 1452-1459, 2004.
5. Ahmad KA, Clement MV, and Pervaiz S. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxideinduced apoptosis. Ann N Y Acad Sci 1010: 365-373, 2003.
6. Akl MR, Ayoub NM, and Sylvester PW. Mechanisms mediating the synergistic anticancer effects of combined gamma-tocotrienol and sesamin treatment. Planta Med 78: 1731-1739, 2012.
7. Alabaster O, Tang Z, Frost A, and Shivapurkar N. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16: 127-132, 1995.
8. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, Haapakoski J, Rautalahti M, Hartman AM, and Palmgren J. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 62: 1427S-1430S, 1995.
9. Albrecht SC, Barata AG, Grosshans J, Teleman AA, and Dick TP. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab 14: 819-829, 2011.
10. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, and Dandona P. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 80: 51-57, 2004.
11. Allen NE, Appleby PN, Roddam AW, Tjonneland A, Johnsen NF, Overvad K, Boeing H, Weikert S, Kaaks R, Linseisen J, Trichopoulou A, Misirli G, Trichopoulos D, Sacerdote C, Grioni S, Palli D, Tumino R, Bueno-de-Mesquita HB, Kiemeney LA, Barricarte A, Larranaga N, Sanchez MJ, Agudo A, Tormo MJ, Rodriguez L, Stattin P, Hallmans G, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Riboli E, Key TJ, and European Prospective Investigation into Cancer and Nutrition. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 88: 1567-1575, 2008.
12. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, and Shields PG. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 59: 602-606, 1999.
13. Antonenkov VD, Grunau S, Ohlmeier S, and Hiltunen JK. Peroxisomes are oxidative organelles. Antioxid Redox Signal 13: 525-537, 2010.
14. Antunes F and Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett 475: 121-126, 2000.
15. Appenzeller-Herzog C. Glutathione-and non-glutathionebased oxidant control in the endoplasmic reticulum. J Cell Sci 124: 847-855, 2011.
16. Arsova-Sarafinovska Z, Matevska N, Eken A, Petrovski D, Banev S, Dzikova S, Georgiev V, Sikole A, Erdem O, Sayal A, Aydin A, and Dimovski AJ. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol 41: 63-70, 2009.
17. Arts IC, Jacobs DR, Jr., Gross M, Harnack LJ, and Folsom AR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13: 373-382, 2002.
18. Atkinson J, Epand RF, and Epand RM. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 44: 739-764, 2008.
19. Aw TY. Determinants of intestinal detoxication of lipid hydroperoxides. Free Radic Res 28: 637-646, 1998.
20. Azzam EI, de Toledo SM, and Little JB. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets 4: 53-64, 2004.
21. Babior BM. NADPH oxidase: an update. Blood 93: 1464-1476, 1999.
22. Badid N, Ahmed FZ, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SA, Benhabib R, Hamzaoui D, and Narce M. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 16: 159-167, 2010.
23. Bagi Z, Koller A, and Kaley G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am J Physiol Heart Circ Physiol 286: H742-H748, 2004.
24. Banhegyi G, Mandl J, and Csala M. Redox-based endoplasmic reticulum dysfunction in neurological diseases. J Neurochem 107: 20-34, 2008.
25. Banim PJ, Luben R, McTaggart A, Welch A, Wareham N, Khaw KT, and Hart AR. Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers. Gut 2012 [Epub ahead of print]; DOI:10.1136/gutjnl-2011-301908.
26. Banning A, Florian S, Deubel S, Thalmann S, Muller-Schmehl K, Jacobasch G, and Brigelius-Flohe R. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antioxid Redox Signal 10: 1491-1500, 2008.
27. Barve A, Khor TO, Nair S, Reuhl K, Suh N, Reddy B, Newmark H, and Kong AN. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer 124: 1693-1699, 2009.
28. Basnet P and Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16: 4567-4598, 2011.
29. Behne D and Kyriakopoulos A. Mammalian seleniumcontaining proteins. Annu Rev Nutr 21: 453-473, 2001.
30. Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, and Lukyanov S. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods 3: 281-286, 2006.
31. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmoller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Ingelman-Sundberg M, Kalina I, Kihara M, Kremers P, Le Marchand L, London SJ, Nazar-Stewart V, Onon-Kihara M, Rannug A, Romkes M, Ryberg D, Seidegard J, Shields P, Strange RC, Stucker I, To-Figueras J, Brennan P, and Taioli E. Meta-and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23: 1343-1350, 2002.
32. Benzie IF. Evolution of dietary antioxidants. Comp Biochem Physiol A Mol Integr Physiol 136: 113-126, 2003.
33. Bertram JS and Bortkiewicz H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 62: 1327S-1336S, 1995.
34. Bhattacharjee S, Pennathur S, Byun J, Crowley J, Mueller D, Gischler J, Hotchkiss RS, and Heinecke JW. NADPH oxidase of neutrophils elevates o,o¢-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys 395: 69-77, 2001.
35. Bienert GP, Schjoerring JK, and Jahn TP. Membrane transport of hydrogen peroxide. Biochim Biophys Acta 1758: 994-1003, 2006.
36. Block KI and Mead MN. Vitamin C in alternative cancer treatment: historical background. Integr Cancer Ther 2: 147-154, 2003.
37. Blokhina O and Fagerstedt KV. Oxidative metabolism, ROS and NO under oxygen deprivation. Plant Physiol Biochem 48: 359-373, 2010.
38. Bobe G, Peterson JJ, Gridley G, Hyer M, Dwyer JT, and Brown LM. Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125: 1147-1154, 2009.
39. Bosetti C, Pelucchi C, and La Vecchia C. Diet and cancer in Mediterranean countries: carbohydrates and fats. Public Health Nutr 12: 1595-1600, 2009.
40. Bou R, Codony R, Tres A, Decker EA, and Guardiola F. Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance. Anal Biochem 377: 1-15, 2008.
41. Bramley P, Elmadfa I, Kafatos A, Kelly F, Manios Y, Roxborough H, Schuch W, Sheehy P, and Wagner K. Vitamin E. J Sci Food Agric 80: 913-938, 2000.
42. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol 45: 466-472, 2010.
43. Brigelius-Flohe R. Selenium compounds and selenoproteins in cancer. Chem Biodivers 5: 389-395, 2008.
44. Brigelius-Flohe R and Kipp AP. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann N Y Acad Sci 1259: 19-25, 2012.
45. Briviba K, Bub A,Moseneder J, Schwerdtle T, Hartwig A, Kulling S, and Watzl B. No differences in DNA damage and antioxidant capacity between intervention groups of healthy, nonsmoking men receiving 2, 5, or 8 servings/ day of vegetables and fruit. Nutr Cancer 60: 164-170, 2008.
46. Brock KE, Ke L, Gridley G, Chiu BC, Ershow AG, Lynch CF, Graubard BI, and Cantor KP. Fruit, vegetables, fibre and micronutrients and risk of US renal cell carcinoma. Br J Nutr 108: 1077-1085, 2012.
47. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
48. Brown K, Morrice P, and Duthie G. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr 60: 383-387, 1994.
49. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300: 535-543, 1993.
50. Cabanillas F. Vitamin C and cancer: what can we conclude-1,609 patients and 33 years later P R Health Sci J 29: 215-217, 2010.
51. Cai C, Ching A, Lagace C, and Linsenmayer T. Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA. Dev Dyn 237: 2676-2683, 2008.
52. Cameron E and Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 75: 4538-4542, 1978.
53. Cardoso AR, Chausse B, da Cunha FM, Luevano-Martinez LA, Marazzi TB, Pessoa PS, Queliconi BB, and Kowaltowski AJ. Mitochondrial compartmentalization of redox processes. Free Radic Biol Med 52: 2201-2208, 2012.
54. Carew JS and Huang P. Mitochondrial defects in cancer. Mol Cancer 1: 9, 2002.
55. Carlsen MH, Halvorsen BL, Holte K, Bohn SK, Dragland S, Sampson L, Willey C, Senoo H, Umezono Y, Sanada C, Barikmo I, Berhe N, Willett WC, Phillips KM, Jacobs DR, Jr., and Blomhoff R. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J 9: 3, 2010.
56. Carlson BA, Yoo MH, Tobe R, Mueller C, Naranjo-Suarez S, Hoffmann VJ, Gladyshev VN, and Hatfield DL. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 33: 1806-1813, 2012.
57. Carnero A. The PKB/AKT pathway in cancer. Curr Pharm Des 16: 34-44, 2010.
58. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, and Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 20: 402-415, 2000.
59. Cattley RC. Peroxisome proliferators and receptormediated hepatic carcinogenesis. Toxicol Pathol 32 Suppl 2: 6-11, 2004.
60. Ceriello A and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823, 2004.
61. Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, and Darley-Usmar V. Prevention of diabetic nephropathy in Ins2( + /)(-)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 432: 9-19, 2010.
62. Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, and Ngan HY. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29: 1742-1750, 2008.
63. Chen H and Shi H. A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions. FEBS Lett 582: 3899-3902, 2008.
64. Chen H and Tappel AL. Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and ( + )-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic Biol Med 18: 949-953, 1995.
65. Chen N and Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta 1793: 1516-1523, 2009.
66. Chen Y, Azad MB, and Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 16: 1040-1052, 2009.
67. Cherubini A, Ruggiero C, Polidori MC, and Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 39: 841-852, 2005.
68. Cho KJ, Seo JM, and Kim JH. Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol Cells 32: 1-5, 2011.
69. Clark LC, Cantor KP, and Allaway WH. Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46: 37-42, 1991.
70. Clark LC, Combs GF, Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Jr., Park HK, Sanders BB, Jr., Smith CL, and Taylor Jr. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963, 1996.
71. Cocheme HM and Murphy MP. Can antioxidants be effective therapeutics Curr Opin Investig Drugs 11: 426-431, 2010.
72. Cocheme HM, Quin C, McQuaker SJ, Cabreiro F, Logan A, Prime TA, Abakumova I, Patel JV, Fearnley IM, James AM, Porteous CM, Smith RA, Saeed S, Carre JE, Singer M, Gems D, Hartley RC, Partridge L, and Murphy MP. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab 13: 340-350, 2011.
73. Comba A, Lin YH, Eynard AR, Valentich MA, Fernandez-Zapico ME, and Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev 30: 325-342, 2011.
74. Cooke MS, Loft S, Olinski R, Evans MD, Bialkowski K, Wagner JR, Dedon PC, Moller P, Greenberg MM, and Cadet J. Recommendations for standardized description of and nomenclature concerning oxidatively damaged nucleobases in DNA. Chem Res Toxicol 23: 705-707, 2010.
75. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, and Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136: 3046-3053, 2006.
76. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, and Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 52: 601-623, 2006.
77. Dandona P, Mohanty P, Hamouda W, Ghanim H, Aljada A, Garg R, and Kumar V. Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations. J Clin Endocrinol Metab 86: 2899-2902, 2001.
78. de Haan JB, Bladier C, Griffiths P, Kelner M, O'Shea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, and Kola I. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem 273: 22528-22536, 1998.
79. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, and Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev CD005195, 2011.
80. Di Mascio P, Murphy ME, and Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53: 194S-200S, 1991.
81. Dickinson BC and Chang CJ. A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc 130: 9638-9639, 2008.
82. Dickinson BC, Srikun D, and Chang CJ. Mitochondrialtargeted fluorescent probes for reactive oxygen species. Curr Opin Chem Biol 14: 50-56, 2010.
83. Diebold I, Flugel D, Becht S, Belaiba RS, Bonello S, Hess J, Kietzmann T, and Gorlach A. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid Redox Signal 13: 425-436, 2010.
84. Dimova EY, Michiels C, and Kietzmann T. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Curr Pharm Des 15: 3867-3877, 2009.
85. Dimova EY, Samoylenko A, and Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal 6: 777-791, 2004.
86. Diwadkar-Navsariwala V, Prins GS, Swanson SM, Birch LA, Ray VH, Hedayat S, Lantvit DL, and Diamond AM. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A 103: 8179-8184, 2006.
87. Dizdaroglu M, Jaruga P, Birincioglu M, and Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32: 1102-1115, 2002.
88. Dotan Y, Lichtenberg D, and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43: 200-227, 2004.
89. Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P, and Hercberg S. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 127: 172-184, 2010.
90. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF, Jr., Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC, and Nutritional Prevention of Cancer Study Group. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95: 1477-1481, 2003.
91. Duthie G and Crozier A. Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care 3: 447-451, 2000.
92. Eberhardt MV, Lee CY, and Liu RH. Antioxidant activity of fresh apples. Nature 405: 903-904, 2000.
93. Egler RA, Fernandes E, Rothermund K, Sereika S, de Souza-Pinto N, Jaruga P, Dizdaroglu M, and Prochownik EV. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxinn Oncogene 24: 8038-8050, 2005.
94. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
95. Fiala ES, Sohn OS, Li H, El-Bayoumy K, and Sodum RS. Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. Carcinogenesis 18: 1809-1815, 1997.
96. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 194: 7-15, 2011.
97. Fisher-Wellman K and Bloomer RJ. Macronutrient specific postprandial oxidative stress: relevance to the development of insulin resistance. Curr Diabetes Rev 5: 228-238, 2009.
98. Floegel A, Kim D, Chung S, Koo SI, and Chun OK. Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods. J Food Compos Anal 24: 1043-1048, 2011.
99. Fortuno A, San Jose G, Moreno MU, Beloqui O, Diez J, and Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 55: 209-215, 2006.
100. Foyer CH and Noctor G. Ascorbate and glutathione: the heart of the redox hub. Plant Physiol 155: 2-18, 2011.
101. Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, and Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A 88: 11003-11006, 1991.
102. Franco R, Schoneveld O, Georgakilas AG, and Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266: 6-11, 2008.
103. Frankel EN, Waterhouse AL, and Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104, 1993.
104. Frantz S, Kelly RA, and Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 276: 5197-5203, 2001.
105. Frederiks WM and Vreeling-Sindelarova H. Ultrastructural localization of xanthine oxidoreductase activity in isolated rat liver cells. Acta Histochem 104: 29-37, 2002.
106. Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS, and Ger LP. Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 33: 1606-1615, 2011.
107. Fukuda R, Kelly B, and Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factorr Cancer Res 63: 2330-2334, 2003.
108. Fukumura H, Sato M, Kezuka K, Sato I, Feng X, Okumura S, Fujita T, Yokoyama U, Eguchi H, Ishikawa Y, and Saito T. Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. J Physiol Sci 62: 251-257, 2012.
109. Gao N, Jiang BH, Leonard SS, Corum L, Zhang Z, Roberts JR, Antonini J, Zheng JZ, Flynn DC, Castranova V, and Shi X. p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J Biol Chem 277: 45041-45048, 2002.
110. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, and Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12: 230-238, 2007.
111. Garcia-Fuentes E, Murri M, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Moreno-Santos I, Tinahones FJ, and Macias-Gonzalez M. PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity 18: 952-958, 2010.
112. Geybels MS, Hutter CM, Kwon EM, Ostrander EA, Fu R, Feng Z, Stanford JL, and Peters U. Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate 2012 [Epub ahead of print]; DOI: 10.1002/ pros.22617.
113. Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, and Martin RM. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade. Cancer Causes Control 23: 1865-1873, 2012.
114. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, and Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005.
115. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/ World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15: 523-526, 1999.
116. Go YM and Jones DP. Redox control systems in the nucleus: mechanisms and functions. Antioxid Redox Signal 13: 489-509, 2010.
117. Go YM, Ziegler TR, Johnson JM, Gu L, Hansen JM, and Jones DP. Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells. Free Radic Biol Med 42: 363-370, 2007.
118. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Jr., Omenn GS, Valanis B, and Williams JH, Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 96: 1743-1750, 2004.
119. Goodman M, Bostick RM, Kucuk O, and Jones DP. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med 51: 1068-1084, 2011.
120. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, and Busse R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89: 47-54, 2001.
121. Gorlach A, Klappa P, and Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8: 1391-1418, 2006.
122. Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cocheme HM, Murphy MP, and Dominiczak AF. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54: 322-328, 2009.
123. Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, Quesenberry CP, Jr., and Caan BJ. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer 118: 2048-2058, 2012.
124. Gupta SC, Hevia D, Patchva S, Park B, Koh W, and Aggarwal BB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal 16: 1295-1322, 2012.
125. Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y, Meyer AJ, and Dick TP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods 5: 553-559, 2008.
126. Gutscher M, Sobotta MC, Wabnitz GH, Ballikaya S, Meyer AJ, Samstag Y, and Dick TP. Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem 284: 31532-31540, 2009.
127. Gutteridge JM and Halliwell B. Antioxidants: molecules, medicines, and myths. Biochem Biophys Res Commun 393: 561-564, 2010.
128. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, and Surmeier DJ. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468: 696-700, 2010.
129. Hail N, Jr., Chen P, Kepa JJ, Bushman LR, and Shearn C. Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl) retinamide-induced reactive oxygen species production and apoptosis. Free Radic Biol Med 49: 109-116, 2010.
130. Halliwell B. Vitamin C and genomic stability. Mutat Res 475: 29-35, 2001.
131. Halliwell B. The antioxidant paradox. Lancet 355: 1179-1180, 2000.
132. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev 57: 104-113, 1999.
133. Halliwell B, Rafter J, and Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects Antioxidant or not Am J Clin Nutr 81: 268S-276S, 2005.
134. Ham AJ and Liebler DC. Vitamin E oxidation in rat liver mitochondria. Biochemistry 34: 5754-5761, 1995.
135. Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MS, and Mizugaki M. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 55: 560-569, 2003.
136. Han X, Shen T, and Lou H. Dietary polyphenols and their biological significance. Int J Mol Sci 2007: 8, 950-988.
137. Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, and Remington SJ. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279: 13044-13053, 2004.
138. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O, and Stein Y. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 85: 47-54, 1990.
139. Hardy M, Chalier F, Ouari O, Finet JP, Rockenbauer A, Kalyanaraman B, and Tordo P. Mito-DEPMPO synthesized from a novel NH2-reactive DEPMPO spin trap: a new and improved trap for the detection of superoxide. Chem Commun 10: 1083-1085, 2007.
140. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, and Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342, 2004.
141. Hileman EA, Achanta G, and Huang P. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin Ther Targets 5: 697-710, 2001.
142. Hille R and Nishino T. Flavoprotein structure and mechanism. Xanthine oxidase and xanthine dehydrogenase. FASEB J 9: 995-1003, 1995.
143. Hirvonen T, Virtamo J, Korhonen P, Albanes D, and Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12: 789-796, 2001.
144. Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP, and VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106: 1453-1459, 2002.
145. Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, and Miller WH, Jr. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 19: 1969-1974, 2008.
146. Hogervorst JG, Baars BJ, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA. The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 40: 485-512, 2010.
147. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, and Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 141: 989S-1009S, 2011.
148. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, and Lillig CH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 33: 1375-1377, 2005.
149. Hopkins MH, Fedirko V, Jones DP, Terry PD, and Bostick RM. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial. Cancer Epidemiol Biomarkers Prev 19: 850-858, 2010.
150. Huang D, Ou B, and Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem 53: 1841-1856, 2005.
151. Huo YY, Li G, Duan RF, Gou Q, Fu CL, Hu YC, Song BQ, Yang ZH, Wu DC, and Zhou PK. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med 44: 1578-1591, 2008.
152. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, Beynon R, Savovic J, and Fairweather-Tait SJ. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 96: 111-122, 2012.
153. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, and Hart CM. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288: C899-C905, 2005.
154. Ichikawa M, Nishino T, Nishino T, and Ichikawa A. Subcellular localization of xanthine oxidase in rat hepatocytes: high-resolution immunoelectron microscopic study combined with biochemical analysis. J Histochem Cytochem 40: 1097-1103, 1992.
155. Imai H and Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 34: 145-169, 2003.
156. Imlay JA. Pathways of oxidative damage. Annu Rev Microbiol 57: 395-418, 2003.
157. Immenschuh S, Baumgart-Vogt E, Tan M, Iwahara S, Ramadori G, and Fahimi HD. Differential cellular and subcellular localization of heme-binding protein 23/ peroxiredoxin I and heme oxygenase-1 in rat liver. J Histochem Cytochem 51: 1621-1631, 2003.
158. Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, and Katayama S. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2 +,Zn2 +-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3-11, 2001.
159. Ito Y, Suzuki S, Yagyu K, Sasaki R, Suzuki K, and Aoki K. Relationship between serum carotenoid levels and cancer death rates in the residents, living in a rural area of Hokkaido, Japan. J Epidemiol 7: 1-8, 1997.
160. Iwasaki M, Inoue M, Sasazuki S, Miura T, Sawada N, Yamaji T, Shimazu T, Willett WC, and Tsugane S. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res Treat 124: 827-834, 2010.
161. Jablonska E, Gromadzinska J, Sobala W, Reszka E, and Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr 47: 47-54, 2008.
162. Jacobs EJ, Connell CJ, Chao A, McCullough ML, Rodriguez C, Thun MJ, and Calle EE. Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter Am J Epidemiol 158: 621-628, 2003.
163. Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, Rodriguez C, Calle EE, and Thun MJ. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156: 1002-1010, 2002.
164. Jamaluddin M, Wang S, Boldogh I, Tian B, and Brasier AR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19: 1419-1433, 2007.
165. James AM, Cocheme HM, Smith RA, and Murphy MP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 280: 21295-21312, 2005.
166. Jang M and Pezzuto JM. Effects of resveratrol on 12- Otetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 134: 81-89, 1998.
167. Jeon YJ, Myung SK, Lee EH, Kim Y, Chang YJ, Ju W, Cho HJ, Seo HG, and Huh BY. Effects of beta-carotene supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr Cancer 63: 1185-1195, 2011.
168. Jokilehto T and Jaakkola PM. The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med 14: 758-770, 2010.
169. Jomova K and Valko M. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des 17: 3460-3473, 2011.
170. Kabat GC, Kim MY, Sarto GE, Shikany JM, and Rohan TE. Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative. Eur J Clin Nutr 66: 549-554, 2012.
171. Kabat GC, Kim MY, Wactawski-Wende J, Shikany JM, Vitolins MZ, and Rohan TE. Intake of antioxidant nutrients and risk of non-Hodgkin's Lymphoma in the Women's Health Initiative. Nutr Cancer 64: 245-254, 2012.
172. Kaikkonen J, Nyyssonen K, Tomasi A, Iannone A, Tuomainen TP, Porkkala-Sarataho E, and Salonen JT. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and D-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study. Free Radic Res 33: 329-340, 2000.
173. Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ,2nd, and Ischiropoulos H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 52: 1-6, 2012.
174. Kamata H, Manabe T, Oka S, Kamata K, and Hirata H. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 519: 231-237, 2002.
175. Kapahi P, Boulton ME, and Kirkwood TB. Positive correlation between mammalian life span and cellular resistance to stress. Free Radic Biol Med 26: 495-500, 1999.
176. Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bohn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, and Blomhoff R. Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers. Br J Nutr 106: 557-571, 2011.
177. Karppi J, Kurl S, Laukkanen JA, and Kauhanen J. Serum beta-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study. Nutr Cancer 64: 361-367, 2012.
178. Kasai H, Okada Y, Nishimura S, Rao MS, and Reddy JK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 49: 2603-2605, 1989.
179. Kazanietz MG. Targeting protein kinase C and ''non-kinase'' phorbol ester receptors: emerging concepts and therapeutic implications. Biochim Biophys Acta 1754: 296-304, 2005.
180. Kietzmann T and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16: 474-486, 2005.
181. Kietzmann T, Jungermann K, and Gorlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb Haemost 89: 666-673, 2003.
182. Kim JJ, Chae SW, Hur GC, Cho SJ, Kim MK, Choi J, Nam SY, Kim WH, Yang HK, and Lee BL. Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology 70: 353-360, 2002.
183. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB, and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 99: 1200-1209, 2007.
184. Kiselev KV. Perspectives for production and application of resveratrol. Appl Microbiol Biotechnol 90: 417-425, 2011.
185. Knebel A, Rahmsdorf HJ, Ullrich A, and Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15: 5314-5325, 1996.
186. Kobliakov VA. Mechanisms of tumor promotion by reactive oxygen species. Biochemistry (Mosc) 75: 675-685, 2010.
187. Koide Y, Urano Y, Kenmoku S, Kojima H, and Nagano T. Design and synthesis of fluorescent probes for selective detection of highly reactive oxygen species in mitochondria of living cells. J Am Chem Soc 129: 10324-10325, 2007.
188. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, and Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 131: 238-242, 2005.
189. Kong Q, Beel JA, and Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses 55: 29-35, 2000.
190. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, and Nishizuka Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A 94: 11233-11237, 1997.
191. Krinsky NI. The antioxidant and biological properties of the carotenoids. Ann N Y Acad Sci 854: 443-447, 1998.
192. Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, and Thompson IM. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 172: 566-577, 2010.
193. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, and Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439-1443, 2003.
194. Kundu JK and Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269: 243-261, 2008.
195. Kurz T, Eaton JW, and Brunk UT. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid Redox Signal 13: 511-523, 2010.
196. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, and Quilliam LA. A molecular redox switch on p21(ras). Structural basis for the nitric oxidep21( ras) interaction. J Biol Chem 272: 4323-4326, 1997.
197. Lauth M. RAS and Hedgehog - partners in crime. Front Biosci 17: 2259-2270, 2011.
198. Lavrovsky Y, Chatterjee B, Clark RA, and Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35: 521-532, 2000.
199. Lee J, Giordano S, and Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 441: 523-540, 2012.
200. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, and Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002.
201. Leibovitz B, Hu ML, and Tappel AL. Dietary supplements of vitamin E, beta-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices. J Nutr 120: 97-104, 1990.
202. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, and La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev 14: 139-142, 2005.
203. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, and Ma J. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65: 2498-2504, 2005.
204. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, and Ma J. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96: 696-703, 2004.
205. Liehr JG. Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol. Am J Clin Nutr 54: 1256S-1260S, 1991.
206. Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, and Laurent-Puig P. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23: 3517-3525, 2005.
207. Lim S, Rashid MA, Jang M, Kim Y, Won H, Lee J, Woo JT, Kim YS, Murphy MP, Ali L, Ha J, and Kim SS. Mitochondria-targeted antioxidants protect pancreatic beta-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol Biochem 28: 873-886, 2011.
208. Lin H, Lu JP, Laflamme P, Qiao S, Shayegan B, Bryskin I, Monardo L, Wilson BC, Singh G, and Pinthus JH. Inter related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol 37: 761-766, 2010.
209. Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS, and Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 164: 644-651, 2006.
210. Linseisen J, Wolfram G, and Miller AB. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1630-1637, 2002.
211. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, and Coltman CA. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. JAMA 301: 39-51, 2009.
212. Liu Q, Berchner-Pfannschmidt U, Moller U, Brecht M, Wotzlaw C, Acker H, Jungermann K, and Kietzmann T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc Natl Acad Sci U S A 101: 4302-4307, 2004.
213. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134: 3479S-3485S, 2004.
214. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, and Ngan HY. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61: 5998-6001, 2001.
215. Long LH, Lan AN, Hsuan FT, and Halliwell B. Generation of hydrogen peroxide by ''antioxidant'' beverages and the effect of milk addition. Is cocoa the best beverage Free Radic Res 31: 67-71, 1999.
216. Lopez-Torres M and Barja G. Lowered methionine ingestion as responsible for the decrease in rodent mitochondrial oxidative stress in protein and dietary restriction possible implications for humans. Biochim Biophys Acta 1780: 1337-1347, 2008.
217. Lu C, Zhang D, Whiteman M, and Armstrong JS. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA Antioxid Redox Signal 10: 651-660, 2008.
218. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L, and Chanvorachote P. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 285: 38832-38840, 2010.
219. Lubos E, Loscalzo J, and Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15: 1957-1997, 2011.
220. Lutsenko EA, Carcamo JM, and Golde DW. Vitamin C prevents DNA mutation induced by oxidative stress. J Biol Chem 277: 16895-16899, 2002.
221. Maffei F, Angeloni C, Malaguti M, Moraga JM, Pasqui F, Poli C, Colecchia A, Festi D, Hrelia P, and Hrelia S. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutat Res 714: 88-92, 2011.
222. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni JF, Jr., Blot WJ, Dong ZW, and Taylor PR. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92: 1753-1763, 2000.
223. Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, Agresti M, Caraglia M, and Sperlongano P. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med 9: 171, 2011.
224. Martinez J and Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59: 865-870, 2000.
225. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB, and De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A 103: 15184-15189, 2006.
226. Mates JM, Segura JA, Alonso FJ, and Marquez J. Oxidative stress in apoptosis and cancer: an update. Arch Toxicol 86: 1649-1665, 2012.
227. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, Watanabe M, Hibi T, and Kitajima M. Increased formation of oxidative DNA damage, 8-hydroxy-2¢-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 151: 87-95, 2000.
228. Matthews JR, Kaszubska W, Turcatti G, Wells TN, and Hay RT. Role of cysteine62 in DNA recognition by the p50 subunit of NF-kappa B. Nucleic Acids Res 21: 1727-1734, 1993.
229. Mayne ST, Handelman GJ, and Beecher G. Beta-Carotene and lung cancer promotion in heavy smokers - a plausible relationship J Natl Cancer Inst 88: 1513-1515, 1996.
230. Mayo JC, Tan DX, Sainz RM, Lopez-Burillo S, and Reiter RJ. Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic Res 37: 543-553, 2003.
231. Maziere C, Dantin F, Conte MA, Degonville J, Ali D, Dubois F, and Maziere JC. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-densitylipoprotein peroxidation. Biochem J 336: 57-62, 1998.
232. McCall MR and Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans Free Radic Biol Med 26: 1034-1053, 1999.
233. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, and Franklin RA. Roles of the Raf/MEK/ ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773: 1263-1284, 2007.
234. McEligot AJ, Yang S, and Meyskens FL, Jr. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu Rev Nutr 25: 261-295, 2005.
235. McGregor GP and Biesalski HK. Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 9: 697-703, 2006.
236. Mehdi MZ, Azar ZM, and Srivastava AK. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1/2 signaling. Cell Biochem Biophys 47: 1-10, 2007.
237. Meyer AJ and Dick TP. Fluorescent protein-based redox probes. Antioxid Redox Signal 13: 621-650, 2010.
238. Meyer AS and Frankel EN. Antioxidant activity of hydroxycinnamic acids on human low-density lipoprotein oxidation. Methods Enzymol 335: 256-265, 2001.
239. Miller ER,3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46, 2005.
240. Miller EW, Tulyathan O, Isacoff EY, and Chang CJ. Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol 3: 263-267, 2007.
241. Mishina NM, Tyurin-Kuzmin PA, Markvicheva KN, Vorotnikov AV, Tkachuk VA, Laketa V, Schultz C, Lukyanov S, and Belousov VV. Does cellular hydrogen peroxide diffuse or act locally Antioxid Redox Signal 14: 1-7, 2011.
242. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79, 2012.
243. Miyagi S, Iwama N, Kawabata T, and Hasegawa K. Longevity and diet in Okinawa, Japan: the past, present and future. Asia Pac J Public Health 15 Suppl: S3-S9, 2003.
244. Modica-Napolitano JS, Kulawiec M, and Singh KK. Mitochondria and human cancer. Curr Mol Med 7: 121-131, 2007.
245. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, and Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75: 767-772, 2002.
246. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85: 2970-2973, 2000.
247. Mol MJTM, de Rijke YB, Demacker PNM, and Stalenhoef AFH. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129: 169-176, 1997.
248. Morgan B, Ezerina D, Amoako TN, Riemer J, Seedorf M, and Dick TP. Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis. Nat Chem Biol 9: 119-125, 2012.
249. Morgan MJ and Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21: 103-115, 2011.
250. Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32: 377-385, 2000.
251. Mueller MJ. Archetype signals in plants: the phytoprostanes. Curr Opin Plant Biol 7: 441-448, 2004.
252. Muqbil1 I, Beck FW, Bao B, Sarkar FH, Mohammad RM, Hadi SM, and Azmi AS. Old Wine in a New Bottle: the Warburg effect and anticancer mechanisms of resveratrol. Curr Pharm Des 18: 1645-1654, 2012.
253. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
254. Murphy MP, Holmgren A, Larsson NG, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nystrom T, Belousov V, Schumacker PT, and Winterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab 13: 361-366, 2011.
255. Myung SK, Kim Y, Ju W, Choi HJ, and Bae WK. Effects of antioxidant supplements on cancer prevention: metaanalysis of randomized controlled trials. Ann Oncol 21: 166-179, 2010.
256. Narisawa T, Fukaura Y, Hasebe M, Ito M, Aizawa R, Murakoshi M, Uemura S, Khachik F, and Nishino H. Inhibitory effects of natural carotenoids, alpha-carotene, betacarotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107: 137-142, 1996.
257. Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, Sakamoto H, Inakuma T, Ishiguro Y, Takayasu J, and Nishino H. Prevention of N-methylnitrosourea- induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res 89: 1003-1008, 1998.
258. Nath RG and Chung FL. Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc Natl Acad Sci U S A 91: 7491-7495, 1994.
259. Navarro J, Obrador E, Carretero J, Petschen I, Avino J, Perez P, and Estrela JM. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med 26: 410-418, 1999.
260. Ndiaye M, Kumar R, and Ahmad N. Resveratrol in cancer management: where are we and where we go from here Ann N Y Acad Sci 1215: 144-149, 2011.
261. Negis Y, Zingg JM, Libinaki R, Meydani M, and Azzi A. Vitamin E and cancer. Nutr Cancer 61: 875-878, 2009.
262. Niethammer P, Grabher C, Look AT, and Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996-999, 2009.
263. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
264. Nishino H, Murakoshi M, Tokuda H, and Satomi Y. Cancer prevention by carotenoids. Arch Biochem Biophys 483: 165-168, 2009.
265. Nohl H and Gille L. The bifunctional activity of ubiquinone in lysosomal membranes. Biogerontology 3: 125-131, 2002.
266. Nomura K, Imai H, Koumura T, Kobayashi T, and Nakagawa Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J 351: 183-193, 2000.
267. Oberley TD, Verwiebe E, Zhong W, Kang SW, and Rhee SG. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med 30: 412-424, 2001.
268. Offord E, van Poppel G, and Tyrrell R. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic Res 33 Suppl: S5-S19, 2000.
269. O'Keefe JH, Gheewala NM, and O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 51: 249-255, 2008.
270. Olson SH, Carlson MD, Ostrer H, Harlap S, Stone A, Winters M, and Ambrosone CB. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol Oncol 93: 615-620, 2004.
271. Orhan H, Coolen S, and Meerman JH. Quantification of urinary o,o¢-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometry. A comparison with ion-trap tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 827: 104-108, 2005.
272. Ostergaard H, Henriksen A, Hansen FG, and Winther Jr. Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein. EMBO J 20: 5853-5862, 2001.
273. Ostman A, Frijhoff J, Sandin A, and Bohmer FD. Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem 150: 345-356, 2011.
274. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96: 2181-2196, 2007.
275. Palafox-Carlos H, Ayala-Zavala JF, and Gonzalez-Aguilar GA. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants. J Food Sci 76: R6-R15, 2011.
276. Patel D, Shukla S, and Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30: 233-245, 2007.
277. Pelicano H, Carney D, and Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7: 97-110, 2004.
278. Persson C, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, Miura T, Ye W, Tsugane S, and JPHC Study Group. Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: A nested case-control study. Carcinogenesis 29: 1042-1048, 2008.
279. Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, Crawford ED, Sturup S, Chanock SJ, and Hayes RB. Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr 85: 209-217, 2007.
280. Petrat F, de Groot H, and Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 356: 61-69, 2001.
281. Petry A, Weitnauer M, and Gorlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 13: 467-487, 2010.
282. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, and Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redoxinduced inhibition of DNA binding. Biochemistry 40: 14134-14142, 2001.
283. Prieme H, Loft S, Nyyssonen K, Salonen JT, and Poulsen HE. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2¢-deoxyguanosine excretion in smokers. Am J Clin Nutr 65: 503-507, 1997.
284. Prime TA, Forkink M, Logan A, Finichiu PG, McLachlan J, Li Pun PB, Koopman WJ, Larsen L, Latter MJ, Smith RA, and Murphy MP. A ratiometric fluorescent probe for assessing mitochondrial phospholipid peroxidation within living cells. Free Radic Biol Med 53: 544-553, 2012.
285. Prutz WA, Butler J, and Land EJ. Interaction of copper(I) with nucleic acids. Int J Radiat Biol 58: 215-234, 1990.
286. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, Mark SD, and Taylor PR. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101: 507-518, 2009.
287. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, and Lee SW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475: 231-234, 2011.
288. Rajneesh CP, Manimaran A, Sasikala KR, and Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 49: 640-643, 2008.
289. Raman M, Chen W, and Cobb MH. Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112, 2007.
290. Ramsey MR and Sharpless NE. ROS as a tumour suppressor Nat Cell Biol 8: 1213-1215, 2006.
291. Rao AV and Snyder DM. Raspberries and human health: a review. J Agric Food Chem 58: 3871-3883, 2010.
292. Rao MS and Reddy JK. Hepatocarcinogenesis of peroxisome proliferators. Ann N Y Acad Sci 804: 573-587, 1996.
293. Rautalahti MT, Virtamo JR, Taylor PR, Heinonen OP, Albanes D, Haukka JK, Edwards BK, Karkkainen PA, Stolzenberg-Solomon RZ, and Huttunen J. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer 86: 37-42, 1999.
294. Ray PD, Huang BW, and Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990, 2012.
295. Rayman MP. Selenium and human health. Lancet 379: 1256-1268, 2012.
296. Rehman A, Collis CS, Yang M, Kelly M, Diplock AT, Halliwell B, and Rice-Evans C. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 246: 293-298, 1998.
297. Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF, Jr., Alberts DS, Clark LC, and Marshall Jr. The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer 60: 155-163, 2008.
298. Reis A, Domingues MR, Oliveira MM, and Domingues P. Identification of free radicals by spin trapping with DEPMPO and MCPIO using tandem mass spectrometry. Eur J Mass Spectrom 15: 689-703, 2009.
299. Reiter E, Azzi A, and Zingg JM. Enhanced anti-proliferative effects of combinatorial treatment of delta-tocopherol and resveratrol in human HMC-1 cells. Biofactors 30: 67-77, 2007.
300. Rhee SG, Chang TS, Jeong W, and Kang D. Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol Cells 29: 539-549, 2010.
301. Richard D, Kefi K, Barbe U, Bausero P, and Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 57: 451-455, 2008.
302. Richard DE, Berra E, and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771, 2000.
303. Richie JP, Jr., Leutzinger Y, Parthasarathy S, Malloy V, Orentreich N, and Zimmerman JA. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J 8: 1302-1307, 1994.
304. Riemer J, Bulleid N, and Herrmann JM. Disulfide formation in the ER and mitochondria: two solutions to a common process. Science 324: 1284-1287, 2009.
305. Roberts LJ and Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-513, 2000.
306. Rodriguez-Cuenca S, Cocheme HM, Logan A, Abakumova I, Prime TA, Rose C, Vidal-Puig A, Smith AC, Rubinsztein DC, Fearnley IM, Jones BA, Pope S, Heales SJ, Lam BY, Neogi SG, McFarlane I, James AM, Smith RA, and Murphy MP. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 48: 161-172, 2010.
307. Rossi M, Bosetti C, Negri E, Lagiou P, and La Vecchia C. Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer 62: 871-877, 2010.
308. Rossi R, Milzani A, Dalle-Donne I, Giustarini D, Lusini L, Colombo R, and Di Simplicio P. Blood glutathione disulfide: in vivo factor or in vitro artifact Clin Chem 48: 742-753, 2002.
309. Rossner P, Jr., Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, and Santella RM. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15: 639-644, 2006.
310. Salonen JT, Nyyssonen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, and Poulsen HE. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248: 377-386, 2000.
311. Sano T, Umeda F, Hashimoto T, Nawata H, and Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 41: 1355-1360, 1998.
312. Satia JA, Littman A, Slatore CG, Galanko JA, and White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 169: 815-828, 2009.
313. Scalbert A and Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 130: 2073S-2085S, 2000.
314. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, and Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44: 192-201, 2011.
315. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, and Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461: 109-113, 2009.
316. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007.
317. Schlachterman A, Valle F, Wall KM, Azios NG, Castillo L, Morell L, Washington AV, Cubano LA, and Dharmawardhane SF. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 1: 19-27, 2008.
318. Schrader M and Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-1766, 2006.
319. Schwarzlander M, Logan DC, Fricker MD, and Sweetlove LJ. The circularly permuted yellow fluorescent protein cpYFP that has been used as a superoxide probe is highly responsive to pH but not superoxide in mitochondria: implications for the existence of superoxide 'flashes'. Biochem J 437: 381-387, 2011.
320. Seet RC, Lee CY, Chan BP, Sharma VK, Teoh HL, Venketasubramanian N, Lim EC, Chong WL, Looi WF, Huang SH, Ong BK, and Halliwell B. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 42: 2326-2329, 2011.
321. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, and Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/ 15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab 8: 237-248, 2008.
322. Sekiguchi M and Tsuzuki T. Oxidative nucleotide damage: consequences and prevention. Oncogene 21: 8895-8904, 2002.
323. Sener DE, Gonenc A, Akinci M, and Torun M. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 25: 377-382, 2007.
324. Seo MS, Kang SW, Kim K, Baines IC, Lee TH, and Rhee SG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346-20354, 2000.
325. Serafini M and Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool Redox Rep 9: 145-152, 2004.
326. Serafini M, Jakszyn P, Lujan-Barroso L, Agudo A, Bas Buenode-Mesquita H, van Duijnhoven FJ, JenabM, Navarro C, Palli D, Boeing H, Wallstrom P, Regner S, Numans ME, Carneiro F, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Grioni S, Panico S, Tumino R, Sacerdote C, Ramon Quiros J, Molina-Montes E, Huerta Castano JM, Barricarte A, Amiano P, Khaw KT,Wareham N, Allen NE, Key TJ, Jeurnink SM, Peeters PH, Bamia C, Valanou E, Trichopoulou A, Kaaks R, Lukanova A, Bergmann MM, Lindkvist B, Stenling R, Johansson I, Dahm CC, Overvad K, Jensen M, Olsen A, Tjonneland A, Lund E, Rinaldi S, Michaud D, Mouw T, Riboli E, and Gonzalez CA. Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study. Int J Cancer 131: E544-E554, 2012.
327. Seren S, Lieberman R, Bayraktar UD, Heath E, Sahin K, Andic F, and Kucuk O. Lycopene in cancer prevention and treatment. Am J Ther 15: 66-81, 2008.
328. Sheikh-Ali M, Chehade JM, and Mooradian AD. The antioxidant paradox in diabetes mellitus. Am J Ther 18: 266-278, 2011.
329. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233: 674-688, 2008.
330. Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev 13: 219-230, 2004.
331. Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L, and Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 11: 403-406, 2005.
332. Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY, Roginsky VA, Rokitskaya TI, Severin FF, Severina II, Simonyan RA, Skulachev MV, Sumbatyan NV, Sukhanova EI, Tashlitsky VN, Trendeleva TA, Vyssokikh MY, and Zvyagilskaya RA. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta 1797: 878-889, 2010.
333. Smith RA and Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 1201: 96-103, 2010.
334. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, and Kasahara T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 274: 10566-10570, 1999.
335. Soyalan B, Minn J, Schmitz HJ, Schrenk D, Will F, Dietrich H, Baum M, Eisenbrand G, and Janzowski C. Apple juice intervention modulates expression of ARE-dependent genes in rat colon and liver. Eur J Nutr 50: 135-143, 2011.
336. Speciale A, Chirafisi J, Saija A, and Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 11: 770-789, 2011.
337. Srikun D, Albers AE, Nam CI, Iavarone AT, and Chang CJ. Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling. J Am Chem Soc 132: 4455-4465, 2010.
338. Stadtman ER. Role of oxidant species in aging. Curr Med Chem 11: 1105-1112, 2004.
339. Suadicani P, Hein HO, and Gyntelberg F. Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study. Eur Respir J 39: 1443-1448, 2012.
340. Sugiyama M, Lin XH, and Costa M. Protective effect of vitamin E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster V79 cells. Mutat Res 260: 19-23, 1991.
341. Supari F, Ungerer T, Harrison DG, and Williams JK. Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys. Circulation 91: 1123-1128, 1995.
342. Supinski GS, Murphy MP, and Callahan LA. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 297: R1095-R1102, 2009.
343. Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 8: E277-E283, 2006.
344. Tachibana H. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci 87: 66-80, 2011.
345. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011.
346. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, and Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291-1297, 2006.
347. Takeuchi H, Fujimoto A, and Hoon DS. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann N Y Acad Sci 1022: 50-54, 2004.
348. Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, Shiomi S, and Inoue M. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J Gastroenterol 39: 1063-1068, 2004.
349. Tan DJ, Bai RK, and Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976, 2002.
350. Teoh-Fitzgerald ML, Fitzgerald MP, Jensen TJ, Futscher BW, and Domann FE. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res 10: 40-51, 2012.
351. Trachootham D, Alexandre J, and Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach Nat Rev Drug Discov 8: 579-591, 2009.
352. Tudek B, Winczura A, Janik J, Siomek A, Foksinski M, and Olinski R. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res 2: 254-284, 2010.
353. Turk PW, Laayoun A, Smith SS, and Weitzman SA. DNA adduct 8-hydroxyl-2¢-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 16: 1253-1255, 1995.
354. Tzonou A, Lipworth L, Garidou A, Signorello LB, Lagiou P, Hsieh C, and Trichopoulos D. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 68: 300-304, 1996.
355. Ungvari Z, Sonntag WE, de Cabo R, Baur JA, and Csiszar A. Mitochondrial protection by resveratrol. Exerc Sport Sci Rev 39: 128-132, 2011.
356. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, and Flohe L. Dual function of the selenoprotein PHGPx during sperm maturation. Science 285: 1393-1396, 1999.
357. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299, 2009.
358. Valero D, Diaz-Mula HM, Zapata PJ, Castillo S, Guillen F, Martinez-Romero D, and Serrano M. Postharvest treatments with salicylic acid, acetylsalicylic acid or oxalic acid delayed ripening and enhanced bioactive compounds and antioxidant capacity in sweet cherry. JAgric Food Chem 59: 5483-5489, 2011.
359. Valko M, Rhodes CJ, Moncol J, Izakovic M, and Mazur M. Free radicals, metals and antioxidants in oxidative stressinduced cancer. Chem Biol Interact 160: 1-40, 2006.
360. Vallim T and Salter AM. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 82: 211-218, 2010.
361. van den Brandt PA, Goldbohm RA, van 't Veer P, Bode P, Dorant E, Hermus RJ, and Sturmans F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 53: 4860-4865, 1993.
362. Vargas AJ and Burd R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev 68: 418-428, 2010.
363. Verhoye E, Langlois MR, and Asklepios Investigators. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk Clin Chem Lab Med 47: 128-137, 2009.
364. Vieira FG, Di Pietro PF, Boaventura BC, Ambrosi C, Rockenbach G, Fausto MA, Crippa CG, and Da Silva EL. Factors associated with oxidative stress in women with breast cancer. Nutr Hosp 26: 528-536, 2011.
365. Viel EC, Benkirane K, JaveshghaniD, TouyzRM, and Schiffrin EL. Xanthine oxidase andmitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 295: H281-H288, 2008.
366. Villamena FA and Zweier JL. Detection of reactive oxygen and nitrogen species by EPR spin trapping. Antioxid Redox Signal 6: 619-629, 2004.
367. Vina J, Gambini J, Lopez-Grueso R, Abdelaziz KM, Jove M, and Borras C. Females live longer than males: role of oxidative stress. Curr Pharm Des 17: 3959-3965, 2011.
368. Virgili F and Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med 45: 1205-1216, 2008.
369. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P, and ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290: 476-485, 2003.
370. Visioli F, Grande S, Bogani P, and Galli C. The role of antioxidants in the mediterranean diets: focus on cancer. Eur J Cancer Prev 13: 337-343, 2004.
371. Vurusaner B, Poli G, and Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 52: 7-18, 2012.
372. Walshe J, Serewko-Auret MM, Teakle N, Cameron S, Minto K, Smith L, Burcham PC, Russell T, Strutton G, Griffin A, Chu FF, Esworthy S, Reeve V, and Saunders NA. Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res 67: 4751-4758, 2007.
373. Wang FS,Wang CJ, Chen YJ, Chang PR, Huang YT, Sun YC, Huang HC, Yang YJ, and Yang KD. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wavestimulated osteoblasts. J Biol Chem 279: 10331-10337, 2004.
374. Wang GL, Jiang BH, and Semenza GL. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factorr Biochem Biophys Res Commun 212: 550-556, 1995.
375. Wang W, Fang H, Groom L, Cheng A, Zhang W, Liu J, Wang X, Li K, Han P, Zheng M, Yin J, Wang W, Mattson MP, Kao JP, Lakatta EG, Sheu SS, Ouyang K, Chen J, Dirksen RT, and Cheng H. Superoxide flashes in single mitochondria. Cell 134: 279-290, 2008.
376. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR, and Mark SD. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79: 80-85, 2004.
377. Weinstein SJ, Peters U, Ahn J, Friesen MD, Riboli E, Hayes RB, and Albanes D. Serum alpha-tocopherol and gammatocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study. PLoS One 7: e40204, 2012.
378. Willcox DC, Willcox BJ, Todoriki H, and Suzuki M. The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr 28 Suppl: 500S-516S, 2009.
379. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4: 278-286, 2008.
380. Winterbourn CC and Metodiewa D. The reaction of superoxide with reduced glutathione. Arch Biochem Biophys 314: 284-290, 1994.
381. Wiseman H and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313: 17-29, 1996.
382. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, and Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140: 517-528, 2010.
383. Wood PM. The potential diagram for oxygen at pHH Biochem J 253: 287-289, 1988.
384. Wood ZA, Poole LB, and Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003.
385. Wood ZA, Schroder E, Robin Harris J, and Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40, 2003.
386. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ, and Santella RM. Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 29: 971-976, 2008.
387. Wu J, Salisbury C, Graham R, Lyons G, and Fenech M. Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males. Environ Mol Mutagen 50: 489-501, 2009.
388. Yang CS and Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res 55: 819-831, 2011.
389. Yao H, Ashihara E, and Maekawa T. Targeting the Wnt/ beta-catenin signaling pathway in human cancers. Expert Opin Ther Targets 15: 873-887, 2011.
390. Yeon JY, Suh YJ, Kim SW, Baik HW, Sung CJ, Kim HS, and Sung MK. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition 27: 912-918, 2011.
391. Yokoe H, Nomura H, Yamano Y, Fushimi K, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Uzawa K, Takiguchi Y, and Tanzawa H. Characterization of intracellular superoxide dismutase alterations in premalignant and malignant lesions of the oral cavity: correlation with lymph node metastasis. J Cancer Res Clin Oncol 135: 1625-1633, 2009.
392. Yoo HY, Chang MS, and Rho HM. Induction of the rat Cu/ Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234: 87-91, 1999.
393. Yue Qian S, Kadiiska MB, Guo Q, and Mason RP. A novel protocol to identify and quantify all spin trapped free radicals from in vitro/in vivo interaction of HO(.-) and DMSO: LC/ESR, LC/MS, and dual spin trapping combinations. Free Radic Biol Med 38: 125-135, 2005.
394. Zhang CX, Ho SC, Chen YM, Fu JH, Cheng SZ, and Lin FY. Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women. Int J Cancer 125: 181-188, 2009.
395. Zhang W, Shu XO, Li H, Yang G, Cai H, Ji BT, Gao J, Gao YT, Zheng W, and Xiang YB. Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst 104: 1173-1181, 2012.
396. Zhang ZF, Kurtz RC, Yu GP, Sun M, Gargon N, Karpeh M, Jr., Fein JS, and Harlap S. Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27: 298-309, 1997.
397. Zhao CR, Gao ZH, and Qu XJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol 34: 523-533, 2010.
398. Ziech D, Franco R, Pappa A, and Panayiotidis MI. Reactive oxygen species (ROS) - induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711: 167-173, 2011.
399. Zielonka J and Kalyanaraman B. Hydroethidine-and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 48: 983-1001, 2010.
400. Zuo XL, Chen JM, Zhou X, Li XZ, and Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 114: 41-53, 2006.